Literature DB >> 28594019

Recent progress in the biomedical applications of polydopamine nanostructures.

Rahila Batul1, Tasnuva Tamanna, Abdul Khaliq, Aimin Yu.   

Abstract

Polydopamine is a dark brown-black insoluble biopolymer produced by autoxidation of dopamine. Although its structure and polymerization mechanism have not been fully understood, there has been a rapid growth in the synthesis and applications of polydopamine nanostructures in biomedical fields such as drug delivery, photothermal therapy, bone and tissue engineering, and cell adhesion and patterning, as well as antimicrobial applications. This article is dedicated to reviewing some of the recent polydopamine developments in these biomedical fields. Firstly, the polymerization mechanism is introduced with a discussion of the factors that influence the polymerization process. The discussion is followed by the introduction of various forms of polydopamine nanostructures and their recent applications in biomedical fields, especially in drug delivery. Finally, the review is summarized followed by brief comments on the future prospects of polydopamine.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28594019     DOI: 10.1039/c7bm00187h

Source DB:  PubMed          Journal:  Biomater Sci        ISSN: 2047-4830            Impact factor:   6.843


  27 in total

1.  Corrosion Inhibition Coating Based on the Self-Assembled Polydopamine Films and Its Anti-Corrosion Properties.

Authors:  Shanjian Li; Changwang Guo; Xin Wang; Chong Guan; Gang Chen
Journal:  Polymers (Basel)       Date:  2022-02-18       Impact factor: 4.329

Review 2.  Polydopamine, harness of the antibacterial potentials-A review.

Authors:  Xiaojun He; Enoch Obeng; Xiaoshuai Sun; Nahyun Kwon; Jianliang Shen; Juyoung Yoon
Journal:  Mater Today Bio       Date:  2022-06-16

3.  A Novel Nanoparticle Preparation to Enhance the Gastric Adhesion and Bioavailability of Xanthatin.

Authors:  Yaqian Zhou; Xingyu Zhu; Shangyang Lin; Chenqi Zhu; Li Wu; Rui Chen; Zhipeng Chen; Weidong Li
Journal:  Int J Nanomedicine       Date:  2020-07-14

4.  Coronary stent CD31-mimetic coating favours endothelialization and reduces local inflammation and neointimal development in vivo.

Authors:  Sergio Diaz-Rodriguez; Charlotte Rasser; Jules Mesnier; Pascale Chevallier; Romain Gallet; Christine Choqueux; Guillaume Even; Neila Sayah; Frédéric Chaubet; Antonino Nicoletti; Bijan Ghaleh; Laurent J Feldman; Diego Mantovani; Giuseppina Caligiuri
Journal:  Eur Heart J       Date:  2021-05-07       Impact factor: 29.983

Review 5.  Nanoparticles modified by polydopamine: Working as "drug" carriers.

Authors:  Anting Jin; Yitong Wang; Kaili Lin; Lingyong Jiang
Journal:  Bioact Mater       Date:  2020-04-18

Review 6.  From Bioinspired Glue to Medicine: Polydopamine as a Biomedical Material.

Authors:  Daniel Hauser; Dedy Septiadi; Joel Turner; Alke Petri-Fink; Barbara Rothen-Rutishauser
Journal:  Materials (Basel)       Date:  2020-04-07       Impact factor: 3.623

7.  Polydopamine Nanosphere with In-Situ Loaded Gentamicin and Its Antimicrobial Activity.

Authors:  Rahila Batul; Mrinal Bhave; Peter J Mahon; Aimin Yu
Journal:  Molecules       Date:  2020-04-30       Impact factor: 4.411

8.  3D-printed titanium implant-coated polydopamine for repairing femoral condyle defects in rabbits.

Authors:  Weiyang Zhong; Jianxiao Li; Chenbo Hu; Zhengxue Quan; Dianming Jiang; Guangbin Huang; Zhigang Wang
Journal:  J Orthop Surg Res       Date:  2020-03-11       Impact factor: 2.359

9.  Reversible Photothermal Modulation of Electrical Activity of Excitable Cells using Polydopamine Nanoparticles.

Authors:  Hamed Gholami Derami; Prashant Gupta; Kuo-Chan Weng; Anushree Seth; Rohit Gupta; Jonathan R Silva; Baranidharan Raman; Srikanth Singamaneni
Journal:  Adv Mater       Date:  2021-07-03       Impact factor: 32.086

10.  Surface modification of doxorubicin-loaded nanoparticles based on polydopamine with pH-sensitive property for tumor targeting therapy.

Authors:  Dongdong Bi; Lei Zhao; Runqi Yu; Haowen Li; Yifei Guo; Xiangtao Wang; Meihua Han
Journal:  Drug Deliv       Date:  2018-11       Impact factor: 6.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.